Effects of Motivational Interviewing on Risky Injecting Practices Among Injecting Drug Users (IDUs)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00794391 |
Recruitment Status
:
Completed
First Posted
: November 20, 2008
Last Update Posted
: April 4, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Hepatitis C | Behavioral: Motivational interviewing Behavioral: Educational intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 219 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Effects of a Brief Motivational Intervention on Risky Injection Practices Among Injecting Drug Users |
Study Start Date : | November 2008 |
Actual Primary Completion Date : | August 2011 |
Actual Study Completion Date : | August 2011 |

Arm | Intervention/treatment |
---|---|
Experimental: Motivational interviewing
Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller & Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
|
Behavioral: Motivational interviewing
Motivational interviewing is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence (Miller & Rollnick. 1993). This 45 minutes individual motivational intervention focuses on risky injection practices.
|
Active Comparator: Educational intervention
The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
|
Behavioral: Educational intervention
The educational intervention is a 45 minutes individual intervention based on a document written by the Québec ministry of health (Québec, Canada). The aim is to inform participants about safe injection practices and to show them how to use sterile injection equipment.
|
- Risky injecting practices [ Time Frame: 3 and 6 month follow-ups ]
- Stages of change for risky injecting practices (adapted from Prochaska & DiClemente) [ Time Frame: 3 and 6 month follow-ups ]
- Drug use (including injecting frequency) [ Time Frame: 3 and 6 months follow-ups ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 16 Years and older (Child, Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- In the last month, at least one cocaine injection
- In the last month, at least one injection with a syringe or another piece of injection equipment that has been used by someone else
- 16 years old or more
- French speaking
- Being able to give informed consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00794391
Canada, Quebec | |
Université de Sherbrooke, service de toxicomanie (Campus Longueuil) | |
Montreal, Quebec, Canada, H2L 1Y8 |
Principal Investigator: | Karine Bertrand, Ph.D. | Université de Sherbrooke | |
Study Chair: | Élise Roy, MD, MSc | Université de Sherbrooke | |
Study Chair: | Carole Morissette, MD, FRCPC | Université de Montréal & Direction de santé publique de Montréal | |
Study Chair: | Jean-François Boivin, MD, FRCPC | McGill University |
Responsible Party: | Karine Bertrand, Professor, Université de Sherbrooke |
ClinicalTrials.gov Identifier: | NCT00794391 History of Changes |
Other Study ID Numbers: |
13940 (FRSQ ID) |
First Posted: | November 20, 2008 Key Record Dates |
Last Update Posted: | April 4, 2014 |
Last Verified: | April 2014 |
Keywords provided by Karine Bertrand, Université de Sherbrooke:
Vulnerable Populations Injecting drug users IDU Risky injecting practices Psychotherapy, brief |
Motivational interviewing Educational activities Clinical trial Risk behavior risk reduction behavior |
Additional relevant MeSH terms:
Hepatitis C Hepatitis, Viral, Human Virus Diseases Flaviviridae Infections |
RNA Virus Infections Hepatitis Liver Diseases Digestive System Diseases |